SCHEMBL18974147

SCHEMBL18974147

Cc1cc(C)cc(CN2C(=O)C(=O)c3ccccc32)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 6/20 0.69
ALDH1A1 P00352 6/20 0.69
ALDH3A1 P30838 4/20 0.69
CHRM1 P11229 3/20 0.69
ALDH2 P05091 3/20 0.69
ACHE P22303 3/20 0.65
TGM2 P21980 2/20 0.64
BCHE P06276 4/20 0.63
CES2 O00748 1/20 0.63
CHRM5 P08912 2/20 0.61
CHRM3 P20309 2/20 0.61
APAF1 O14727 1/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
MAPT P10636 1/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 1/20 0.61
ALOX12 P18054 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18974299 0.88 ALDH1A1 (0.69) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL10975507 0.86 CES1 (0.77) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL30774290 0.86 CES1 (0.77) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL18288159 0.83 CES1 (0.90) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL30774321 0.83 TGM2 (0.67) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL18974146 0.82 CES1 (0.66) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL8816419 0.82 CASP3 (0.56) ALDH1A1MAPTALOX15TSHRHSD17B10
SCHEMBL2087729 0.82 ALDH1A1 (1.00) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL29506660 0.82 ALDH1A1 (1.00) CES1ALDH1A1ALDH3A1CHRM1ALDH2
SCHEMBL18974309 0.81 CES1 (0.77) CES1ALDH1A1ALDH3A1CHRM1ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed